Weekly Paclitaxel With or Without Pazopanib in Platinum Resistant or Refractory Ovarian Cancer

NCT01644825 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: paclitaxel
DRUG: pazopanib

Sponsor

National Cancer Institute, Naples